Targeting tnfr2 as a novel therapeutic strategy for alzheimer’s disease

HIGHLIGHTS

  • who: Ulrich L. M. Eisel from the Department of Molecular Neurobiology, Groningen Institute for Evolutionary Life Sciences, Faculty of Science and Engineering, University of Groningen, Groningen, Netherlands, Department of Neurology and Alzheimer Center, Shimane University, Japan have published the research: Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer's Disease, in the Journal: (JOURNAL) of 04/02/2019
  • what: This study shows that the solely inhibition of solTNF and, thus, TNFR1 by XPro-1595 might not be sufficient to protect mice from EAE.

SUMMARY

    TNF plays a vital role in . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?